These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23466062)

  • 21. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
    Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
    Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. γδ T cells and multiple sclerosis: Friends, foes, or both?
    Chen Z; Freedman MS
    Autoimmun Rev; 2011 Apr; 10(6):364-7. PubMed ID: 21195807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell trafficking competence is required for CNS invasion.
    Lees JR; Archambault AS; Russell JH
    J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?
    Meier UC; Giovannoni G; Tzartos JS; Khan G
    Clin Exp Immunol; 2012 Jan; 167(1):1-6. PubMed ID: 22132878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune reactions in the central nervous system].
    Iivanainen M; Taskinen E
    Duodecim; 1986; 102(5):281-9. PubMed ID: 3486107
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunological aspects of multiple sclerosis].
    Miyagishi R; Fukaura H; Fukazawa T; Tashiro K
    No To Shinkei; 1993 Oct; 45(10):917-24. PubMed ID: 8268031
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disruption of the blood-brain barrier in inflammatory neurological diseases].
    Shimizu F; Kanda T
    Brain Nerve; 2013 Feb; 65(2):165-76. PubMed ID: 23399674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.
    Laplaud DA; Berthelot L; Miqueu P; Bourcier K; Moynard J; Oudinet Y; Guillet M; Ruiz C; Oden N; Brouard S; Guttmann CR; Weiner HL; Khoury SJ; Soulillou JP
    J Neuroimmunol; 2006 Aug; 177(1-2):151-60. PubMed ID: 16806500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
    Pender MP
    Brain; 2009 Dec; 132(Pt 12):3196-8. PubMed ID: 20008341
    [No Abstract]   [Full Text] [Related]  

  • 30. Human immune studies in multiple sclerosis.
    Bar-Or A
    Adv Neurol; 2006; 98():91-109. PubMed ID: 16400829
    [No Abstract]   [Full Text] [Related]  

  • 31. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C; Alvarez JI; Prat A
    FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent prognosis on etiology and pathophysiology of multiple sclerosis].
    Niino M
    Nihon Rinsho; 2013 May; 71(5):807-10. PubMed ID: 23777086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis.
    Hafler DA; Slavik JM; Anderson DE; O'Connor KC; De Jager P; Baecher-Allan C
    Immunol Rev; 2005 Apr; 204():208-31. PubMed ID: 15790361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
    Engelhardt B; Ransohoff RM
    Trends Immunol; 2012 Dec; 33(12):579-89. PubMed ID: 22926201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients.
    Le Berre L; Rousse J; Gourraud PA; Imbert-Marcille BM; Salama A; Evanno G; Semana G; Nicot A; Dugast E; Guérif P; Adjaoud C; Freour T; Brouard S; Agbalika F; Marignier R; Brassat D; Laplaud DA; Drouet E; Van Pesch V; Soulillou JP
    Clin Immunol; 2017 Jul; 180():128-135. PubMed ID: 28506921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection.
    Ohga S; Nomura A; Takada H; Ihara K; Kawakami K; Yanai F; Takahata Y; Tanaka T; Kasuga N; Hara T
    J Infect Dis; 2001 Jan; 183(1):1-7. PubMed ID: 11106535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy.
    Kieseier BC; Archelos JJ; Storch M; Gold R; Hartung HP
    Wien Klin Wochenschr; 1999 Sep; 111(17):728-37. PubMed ID: 10526397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.